Telix Seeks Reset With FDA Filing While Sales Growth Holds Steady
Why Is Telix Pharma Stock Soaring Tuesday?
Telix Pharmaceuticals Reports Strong Full-Year Revenue, But Shares Remain Under Pressure
Telix Pharmaceuticals Enters Q4 On Strong Footing With Stabilized Pricing Pressures, Upgraded Annual Sales Guidance
Telix Gets Second FDA Rejection For Kidney Cancer Drug
US FDA seeks more information on Telix Pharma's diagnostic drug for kidney cancer